140 related articles for article (PubMed ID: 30023395)
1. BLU-285-the breakthrough in treatment of patients with aggressive systemic mastocytosis and gastrointestinal stromal tumor.
Schneider-Stock R
Ann Transl Med; 2018 Jun; 6(11):232. PubMed ID: 30023395
[No Abstract] [Full Text] [Related]
2. Targeting kinases with precision.
Gardino AK; Evans EK; Kim JL; Brooijmans N; Hodous BL; Wolf B; Lengauer C
Mol Cell Oncol; 2018; 5(3):e1435183. PubMed ID: 30250891
[TBL] [Abstract][Full Text] [Related]
3. Rapid Responses to Avapritinib (BLU-285) in Mastocytosis.
Cancer Discov; 2018 Feb; 8(2):133. PubMed ID: 29233825
[TBL] [Abstract][Full Text] [Related]
4. A precision therapy against cancers driven by
Evans EK; Gardino AK; Kim JL; Hodous BL; Shutes A; Davis A; Zhu XJ; Schmidt-Kittler O; Wilson D; Wilson K; DiPietro L; Zhang Y; Brooijmans N; LaBranche TP; Wozniak A; Gebreyohannes YK; Schöffski P; Heinrich MC; DeAngelo DJ; Miller S; Wolf B; Kohl N; Guzi T; Lydon N; Boral A; Lengauer C
Sci Transl Med; 2017 Nov; 9(414):. PubMed ID: 29093181
[TBL] [Abstract][Full Text] [Related]
5. Systemic mastocytosis: A rare cause of non-cirrhotic portal hypertension.
Martins C; Teixeira C; Ribeiro S; Trabulo D; Cardoso C; Mangualde J; Freire R; Gamito É; Alves AL; Cremers I; Alves C; Neves A; Oliveira AP
World J Gastroenterol; 2016 Jul; 22(28):6559-64. PubMed ID: 27605890
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis, clinical features, and treatment advances in mastocytosis.
Pardanani A; Akin C; Valent P
Best Pract Res Clin Haematol; 2006; 19(3):595-615. PubMed ID: 16781490
[TBL] [Abstract][Full Text] [Related]
7. Novel approaches to treating advanced systemic mastocytosis.
Gilreath JA; Tchertanov L; Deininger MW
Clin Pharmacol; 2019; 11():77-92. PubMed ID: 31372066
[TBL] [Abstract][Full Text] [Related]
8. [Systemic mastocytosis: significance of contemporary methods of imaging in diagnosis of this disease].
Błaszczyk B; Brzezińska-Błaszczyk E
Przegl Lek; 1994; 51(6):249-54. PubMed ID: 7938660
[TBL] [Abstract][Full Text] [Related]
9. In utero presentation of aggressive systemic mastocytosis in a neonate.
Huang A; Fiadorchanka N; Brar K; Balderacchi JL; Glick SA
Br J Dermatol; 2017 Nov; 177(5):1439-1441. PubMed ID: 28369700
[TBL] [Abstract][Full Text] [Related]
10. Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis.
Ke H; Kazi JU; Zhao H; Sun J
Cell Biosci; 2016; 6():55. PubMed ID: 27777718
[TBL] [Abstract][Full Text] [Related]
11. Stem cell factor receptor gene mutation: Achalasia, mastocytosis and gastrointestinal stromal tumors.
Tustumi F; Szor DJ; Sallum RAA; Cecconello I
Cancer Genet; 2020 Feb; 241():66. PubMed ID: 31780427
[No Abstract] [Full Text] [Related]
12. Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis.
Hartmann K; Wardelmann E; Ma Y; Merkelbach-Bruse S; Preussner LM; Woolery C; Baldus SE; Heinicke T; Thiele J; Buettner R; Longley BJ
Gastroenterology; 2005 Sep; 129(3):1042-6. PubMed ID: 16143141
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal abnormalities and involvement in systemic mastocytosis.
Jensen RT
Hematol Oncol Clin North Am; 2000 Jun; 14(3):579-623. PubMed ID: 10909042
[TBL] [Abstract][Full Text] [Related]
14. Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients.
Theoharides TC; Boucher W; Spear K
Int Arch Allergy Immunol; 2002 Aug; 128(4):344-50. PubMed ID: 12218373
[TBL] [Abstract][Full Text] [Related]
15. Systemic mastocytosis: classification, pathogenesis, diagnosis, and treatment.
Bunimovich O; Grassi M; Baer MR
Cutis; 2009 Jan; 83(1):29-36. PubMed ID: 19271568
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal manifestations in mastocytosis: a study of 83 patients.
Sokol H; Georgin-Lavialle S; Canioni D; Barete S; Damaj G; Soucie E; Bruneau J; Chandesris MO; Suarez F; Launay JM; Aouba A; Grandpeix-Guyodo C; Lanternier F; Grosbois B; de Gennes C; Cathébras P; Fain O; Hoyeau-Idrissi N; Dubreuil P; Lortholary O; Beaugerie L; Ranque B; Hermine O
J Allergy Clin Immunol; 2013 Oct; 132(4):866-73.e1-3. PubMed ID: 23890756
[TBL] [Abstract][Full Text] [Related]
17. [Systemic mastocytosis. A review of current diagnostic and therapeutic approaches].
Pari F; Zamagni MD; Carnevali C; Pagani M; Rabbi C; Cantore M; Cavazzini G; Aitini E; Smerieri F
Recenti Prog Med; 1999 Mar; 90(3):169-72. PubMed ID: 10228358
[TBL] [Abstract][Full Text] [Related]
18. A familial germline mutation in KIT associated with achalasia, mastocytosis and gastrointestinal stromal tumors shows response to kinase inhibitors.
Halpern AL; Torphy RJ; McCarter MD; Sciotto CG; Glode LM; Robinson WA
Cancer Genet; 2019 Apr; 233-234():1-6. PubMed ID: 31109590
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of tryptase in anaphylaxis and mastocytosis.
Schwartz LB
Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288
[TBL] [Abstract][Full Text] [Related]
20. Kit: molecule of interest for the diagnosis and treatment of mastocytosis and other neoplastic disorders.
Patnaik MM; Tefferi A; Pardanani A
Curr Cancer Drug Targets; 2007 Aug; 7(5):492-503. PubMed ID: 17691909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
